What Makes a Protein Sequence a Prion?

PLoS Computational Biology

Volumn 11, Issue 1, 2015, Pages

  Sabate, Raimon ^a,b   Rousseau, Frederic ^c,d   Schymkowitz, Joost ^c,d   Ventura, Salvador ^e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS;

ALZHEIMER; AMINO ACIDS COMPOSITIONS; AMYLOID DISEASE; CANDIDATE SEQUENCES; IDENTIFICATION AND EVALUATION; PRIMARY SEQUENCES; PROPERTY; PROTEIN SEQUENCES; SPECIFIC SEQUENCES; STRUCTURAL CONVERSION;

AMINO ACIDS;

AMYLOID PROTEIN; ASPARAGINE; GLUTAMINE; PRION PROTEIN; AMYLOID; FUNGAL PROTEIN; PRION;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; PROTEIN DOMAIN; PROTEIN STRUCTURE; YEAST; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PRION;

AMINO ACID SEQUENCE; AMYLOID; FUNGAL PROTEINS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR SEQUENCE DATA; PRIONS;

EID: 84922226021     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004013     Document Type: Article

References (45)

1. Chiti F, Dobson CM, (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333–366.
2. Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, et al. (2012) Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc Natl Acad Sci U S A 109: 11025–11030.
3. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11: 909–913.
4. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, et al. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106: 13010–13015.
5. Aguzzi A, Rajendran L, (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64: 783–790.
6. Uptain SM, Lindquist S, (2002) Prions as protein-based genetic elements. Annu Rev Microbiol 56: 703–741.
7. Michelitsch MD, Weissman JS, (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci U S A 97: 11910–11915.
8. Alberti S, Halfmann R, King O, Kapila A, Lindquist S, (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137: 146–158.
9. de la Paz ML, Serrano L, (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A 101: 87–92.
10. Ross ED, Toombs JA, (2010) The effects of amino acid composition on yeast prion formation and prion domain interactions. Prion 4: 60–65.
11. Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, et al. (2004) Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A 101: 7258–7263.
12. Esteras-Chopo A, Serrano L, de la Paz ML, (2005) The amyloid stretch hypothesis: Recruiting proteins toward the dark side. PNAS %R 101073/pnas0505905102 102: 16672–16677.
13. Teng PK, Eisenberg D, (2009) Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel 22: 531–536.
14. Castillo V, Grana-Montes R, Sabate R, Ventura S, (2011) Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnology Journal 6: 674–685.
15. Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, et al. (2012) De novo design of synthetic prion domains. Proc Natl Acad Sci U S A 109: 6519–6524.
16. Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nature Methods 7: 237–242.
17. Toombs JA, McCarty BR, Ross ED, (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30: 319–332.
18. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447: 453–457.
19. Balbirnie M, Grothe R, Eisenberg DS, (2001) An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc Natl Acad Sci U S A 98: 2375–2380.
20. Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, et al. (2008) Amyloid fibrils of the HET-s(218–289) prion form a beta solenoid with a triangular hydrophobic core. Science 319: 1523–1526.
21. Wasmer C, Zimmer A, Sabate R, Soragni A, Saupe SJ, et al. (2010) Structural similarity between the prion domain of HET-s and a homologue can explain amyloid cross-seeding in spite of limited sequence identity. Journal of Molecular Biology 402: 311–325.
22. Adessi C, Frossard MJ, Boissard C, Fraga S, Bieler S, et al. (2003) Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem 278: 13905–13911.
23. Beerten J, Schymkowitz J, Rousseau F, (2012) Aggregation prone regions and gatekeeping residues in protein sequences. Current Topics in Medicinal Chemistry 12: 2470–2478.
24. Rousseau F, Serrano L, Schymkowitz JW, (2006) How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol 355: 1037–1047.
25. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, et al. (2005) Correlation of structural elements and infectivity of the HET-s prion. Nature 435: 844–848.
26. Mukrasch MD, Biernat J, von Bergen M, Griesinger C, Mandelkow E, et al. (2005) Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions. J Biol Chem 280: 24978–24986.
27. Miller Y, Ma B, Nussinov R, (2011) Synergistic interactions between repeats in tau protein and Abeta amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry 50: 5172–5181.
28. Margittai M, Langen R, (2004) Template-assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci U S A 101: 10278–10283.
29. Mukrasch MD, von Bergen M, Biernat J, Fischer D, Griesinger C, et al. (2007) The "jaws" of the tau-microtubule interaction. J Biol Chem 282: 12230–12239.
30. Eliezer D, Barre P, Kobaslija M, Chan D, Li X, et al. (2005) Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation. Biochemistry 44: 1026–1036.
31. Raz Y, Miller Y, (2013) Interactions between Abeta and mutated Tau lead to polymorphism and induce aggregation of Abeta-mutated tau oligomeric complexes. PLoS One 8: e73303.
32. King OD, Gitler AD, Shorter J, (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Research 1462: 61–80.
33. Espinosa Angarica V, Ventura S, Sancho J, (2013) Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genomics 14: 316.
34. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495: 467–473.
35. Scarafone N, Pain C, Fratamico A, Gaspard G, Yilmaz N, et al. (2012) Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein. PLoS One 7: e31253.
36. Halfmann R, Alberti S, Krishnan R, Lyle N, O'Donnell CW, et al. (2011) Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell 43: 72–84.
37. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, et al. (2005) FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435–3438.
38. http://www.expasy.org/tools/pscale/A.A.Swiss-Prot.html.
39. Gonzalez Nelson AC, Paul KR, Petri M, Flores N, Rogge RA, et al. (2014) Increasing prion propensity by hydrophobic insertion. PLoS One 9: e89286.
40. Tompa P, (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27: 527–533.
41. Dorsman JC, Pepers B, Langenberg D, Kerkdijk H, Ijszenga M, et al. (2002) Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells. Hum Mol Genet 11: 1487–1496.
42. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW, (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880–884.
43. Tanaka M, Collins SR, Toyama BH, Weissman JS, (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585–589.
44. Centor RM, Schwartz JS, (1985) An evaluation of methods for estimating the area under the receiver operating characteristic (ROC) curve. Medical Decision Making 5: 149–156.
45. Fluss R, Faraggi D, Reiser B, (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47: 458–472.